Foxo3a-Mediated DNMT3B Impedes Cervical Cancer Cell Proliferation and Migration Capacities through Suppressing PTEN Promoter Methylation

References

• Guzel C, van Sten-Van’t Hoff J, de Kok I, et al. Molecular markers for cervical cancer screening. Expert Rev Proteomics. 2021;18(8):1–8. doi:10.1080/14789450.2021.1980387.
   PubMed Web of Science ®Google Scholar
• Francies FZ, Bassa S, Chatziioannou A, Kaufmann AM, Dlamini Z. Splicing genomics events in cervical cancer: insights for phenotypic stratification and biomarker potency. Genes. 2021;12(2):130. doi:10.3390/genes12020.
   PubMed Web of Science ®Google Scholar
• Dorji T, Tshomo U, Gyamtsho S, Tamang ST, Wangmo S, Pongpirul K. Gender-neutral HPV elimination, cervical cancer screening, and treatment: experience from Bhutan. Int J Gynaecol Obstet. 2022;156(3):425–429. doi:10.1002/ijgo.13728.
   PubMed Web of Science ®Google Scholar
• He M, Xia L, Li J. Potential mechanisms of plant-derived natural products in the treatment of cervical cancer. Biomolecules. 2021;11(10):1539. doi:10.3390/biom1110.
   PubMed Web of Science ®Google Scholar
• Rogers L, Siu SS, Luesley D, Bryant A, Dickinson HO. Radiotherapy and chemoradiation after surgery for early cervical cancer. Cochrane Database Syst Rev. 2012;5(5):CD007583. doi:10.1002/14651858.CD007583.pub3.
   PubMedGoogle Scholar
• Burmeister CA, Khan SF, Schafer G, et al. Cervical cancer therapies: Current challenges and future perspectives. Tumour Virus Res. 2022;13:200238. doi:10.1016/j.tvr.2022.200238.
   PubMedGoogle Scholar
• Chen GD, Qian DY, Li ZG, Fan GY, You KL, Wu YL. Down-regulation of p16 and MGMT promotes the anti-proliferative and pro-apoptotic effects of 5-Aza-dC and radiation on cervical cancer cells. Cell Biochem Funct. 2017;35(8):488–496. doi:10.1002/cbf.3282.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Fernandez de Mattos S, van der Horst A, et al. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol. 2002;22(22):7842–7852. doi:10.1128/MCB.22.22.7842-7852.2002.
   PubMed Web of Science ®Google Scholar
• Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 2007;7(11):847–859. doi:10.1038/nrc2223.
   PubMed Web of Science ®Google Scholar
• Fernandez de Mattos S, Villalonga P, Clardy J, Lam EW. FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells. Mol Cancer Ther. 2008;7(10):3237–3246. doi:10.1158/1535-7163.MCT-08-0398.
   PubMed Web of Science ®Google Scholar
• Shiota M, Yokomizo A, Kashiwagi E, et al. Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin. Cancer Sci. 2010;101(5):1177–1185. doi:10.1111/j.1349-7006.2010.01503.x.
   PubMed Web of Science ®Google Scholar
• Khatri S, Yepiskoposyan H, Gallo CA, Tandon P, Plas DR. FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1. J Biol Chem. 2010;285(21):15960–15965. doi:10.1074/jbc.M110.121871.
   PubMed Web of Science ®Google Scholar
• Yung MM, Chan DW, Liu VW, Yao KM, Ngan HY. Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade. BMC Cancer. 2013;13:327. doi:10.1186/1471-2407-13-327.
   PubMed Web of Science ®Google Scholar
• Li W, Wang Y, Fang X, et al. Differential expression and clinical significance of DNA methyltransferase 3B (DNMT3B), phosphatase and tensin homolog (PTEN) and human MutL homologs 1 (hMLH1) in endometrial carcinomas. Med Sci Monit. 2017;23:938–947. doi:10.12659/msm.902267.
   PubMed Web of Science ®Google Scholar
• Li W, Huang K, Wen F, et al. LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN. EBioMedicine. 2019;44:298–310. doi:10.1016/j.ebiom.2019.05.055.
   PubMed Web of Science ®Google Scholar
• Lin N, Yao Z, Xu M, et al. Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells. J Exp Clin Cancer Res. 2019;38(1):244. doi:10.1186/s13046-019-1237-5.
   PubMedGoogle Scholar
• Yang YC, Tang YA, Shieh JM, Lin RK, Hsu HS, Wang YC. DNMT3B overexpression by deregulation of FOXO3a-mediated transcription repression and MDM2 overexpression in lung cancer. J Thorac Oncol. 2014;9(9):1305–1315. doi:10.1097/JTO.0000000000000240.
   PubMed Web of Science ®Google Scholar
• Zhou W, Xu S, Chen X, Wang C. HOTAIR suppresses PTEN via DNMT3b and confers drug resistance in acute myeloid leukemia. Hematology. 2021;26(1):170–178. doi:10.1080/16078454.2021.1880733.
   PubMed Web of Science ®Google Scholar
• Qin G, Li P, Xue Z. Triptolide induces protective autophagy and apoptosis in human cervical cancer cells by downregulating Akt/mTOR activation. Oncol Lett. 2018;16(3):3929–3934. doi:10.3892/ol.2018.9074.
   PubMed Web of Science ®Google Scholar
• Liu H, Song Y, Qiu H, et al. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis. Cell Death Differ. 2020;27(3):966–983. doi:10.1038/s41418-019-0389-3.
   PubMed Web of Science ®Google Scholar
• Habrowska-Górczyńska DE, Kozieł MJ, Kowalska K, Piastowska-Ciesielska AW. FOXO3a and its regulators in prostate cancer. IJMS. 2021;22(22):12530. doi:10.3390/ijms2222.
   Google Scholar
• Potente M, Urbich C, Sasaki K-i, et al. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest. 2005;115(9):2382–2392. doi:10.1172/JCI23126.
   PubMed Web of Science ®Google Scholar
• Tang X, Liu S, Ding Y, et al. Serum circular FoxO3a serves as a novel prognostic biomarker in squamous cervical cancer. Cancer Manag Res. 2020;12:2531–2540. doi:10.2147/CMAR.S243329.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li Y, She G, et al. Resveratrol induces cervical cancer HeLa cell apoptosis through the activation and nuclear translocation promotion of FOXO3a. Pharmazie. 2020;75(6):250–254. doi:10.1691/ph.2020.0386.
   PubMed Web of Science ®Google Scholar
• Qi L, Wang Y, Su S, et al. Sodium selenite inhibits cervical cancer growth via ROS mediated AMPK/FOXO3a/GADD45a axis. Chem Biol Interact. 2022;367:110171. doi:10.1016/j.cbi.2022.110171.
   PubMed Web of Science ®Google Scholar
• Leonardi S, Buttarelli M, De Stefano I, et al. The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer. Oncotarget. 2017;8(55):94247–94258. doi:10.18632/oncotarget.21686.
   PubMedGoogle Scholar
• Fei M, Zhao Y, Wang Y, et al. Low expression of Foxo3a is associated with poor prognosis in ovarian cancer patients. Cancer Invest. 2009;27(1):52–59. doi:10.1080/07357900802146204.
   PubMed Web of Science ®Google Scholar
• Lees-Murdock DJ, Lau HT, Castrillon DH, De Felici M, Walsh CP. DNA methyltransferase loading, but not de novo methylation, is an oocyte-autonomous process stimulated by SCF signalling. Dev Biol. 2008;321(1):238–250. doi:10.1016/j.ydbio.2008.06.024.
   PubMed Web of Science ®Google Scholar
• Stresemann C, Brueckner B, Musch T, Stopper H, Lyko F. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res. 2006;66(5):2794–2800. doi:10.1158/0008-5472.CAN-05-2821.
   PubMed Web of Science ®Google Scholar
• Shames DS, Minna JD, Gazdar AF. DNA methylation in health, disease, and cancer. Curr Mol Med. 2007;7(1):85–102. doi:10.2174/156652407779940413.
   PubMed Web of Science ®Google Scholar
• Wu Y, Meng L, Wang H, et al. Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis. Oncol Rep. 2006;16(3):625–629.
   PubMed Web of Science ®Google Scholar
• Woo HJ, Kim SJ, Song KJ, et al. Hypermethylation of the tumor-suppressor cell adhesion molecule 1 in human papillomavirus-transformed cervical carcinoma cells. Int J Oncol. 2015;46(6):2656–2662. doi:10.3892/ijo.2015.2945.
   PubMed Web of Science ®Google Scholar